Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Thank You!

    Your message has been sent.

    Oops, message not sent.

    Please make sure fields are complete.

    News

    Chondrosarcoma Foundation Introduces a new Patient Guide: Making the Decision to enroll in a Clinical Trial.


    Typically after surgery, it is important to know what post-surgical options are available. Making the decision to enroll in a clinical trial is one of those options and maybe one of the most important decisions chondrosarcoma patients and their…

    Read Article

    Chondrosarcoma Foundation Efforts to Promote Genomic Sequencing


    Genomic sequencing is a promising tool for expanding the treatment options for chondrosarcoma patients. Genomic sequencing technologies are capable of characterizing known and novel clinically relevant biomarkers, like IDH1/2, and is becoming a…

    Read Article

    Dan Hurley, M.D. Endowment Fund for Insurance Authorizations


    Daniel Brian Hurley, M.D. passed away August 3, 2023, from dedifferentiated chondrosarcoma at age 50 surrounded by his loved ones. His wife Traci and their three kids Rachel, Sam, and Sarah were the light of his life. His family, including his…

    Read Article

    Call for Action


    Be Part of the First full Analysis of the Chondrosarcoma Patient Registry https://chondrosarcoma.iamrare.org It is not too late to sign up to participate in the Chondrosarcoma Patient Registry. The Chondrosarcoma Foundation has been preparing to…

    Read Article

    Thank You for Supporting Chondrosarcoma Awareness Day


    Thank You!!!! To Everyone that participated in Chondrosarcoma Awareness Day. It is wonderful to see people from all over the globe come together to honor our CS survivors and those who lost their battle to this terrible bone cancer. And it is great…

    Read Article

    Final Tribute and Introduction of the Daniel B. Hurley, M.D. Endowment Fund


    Tomorrow, February 6 is Chondrsarcoma Awareness Day. Join the Fight Wear something Yellow. Take a picture (family, friends, work colleagues) and post it to #cswecare #chondrosarcoma #chondrosarcomafoundation Sign our Petition to support more…

    Read Article

    Tuesday February 6 is Chondrosarcoma Awareness Day.


    This coming Tuesday, February 6 is Chondrsarcoma Awareness Day. Join the Fight Wear something Yellow. Take a picture (family, friends, work colleagues) and post it to #cswecare #chondrosarcoma #chondrosarcomafoundation Sign our Petition to…

    Read Article

    Preclinical Characterization and Phase I Trial Results,of INBRX-109, A Third-Generation, Recombinant,,Humanized, Death Receptor 5 Agonist Antibody,,in Chondrosarcoma


    Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma Vivek Subbiah1, Sant P. Chawla2, Anthony P. Conley3, Breelyn A. Wilky4, Anthony…

    Read Article

    Contact Information


    If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

    **A Registered 501c3 Non-Profit Charity Organization. All donations are tax-deductible.**

    Send a Message